Cerebrospinal Fluid (CSF) Management Market worth 1.56 Billion USD by 2022

According to the new market research report Cerebrospinal Fluid (CSF) Management Market by Product (Shunts (Ventriculoperitoneal, Ventriculoatrial, Adjustable Valve), External Drainage Systems (EVD, Lumbar Drainage)), End User (Pediatric, Adult, Geriatric) – Global Forecast to 2022″, published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).

The global cerebrospinal fluid (CSF) management market is expected to reach USD 1.56 Billion by 2022 from USD 1.26 Billion in 2017, at a CAGR of 4.4%. The key factors driving the growth of this market include the high prevalence of hydrocephalus and the subsequent increase in the number of shunting procedures and the growing geriatric population.

Don’t miss out on business opportunities in Cerebrospinal Fluid Management Market.
Speak to our analyst and gain crucial industry insights that will help your business grow:  https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=160672575

Based on product, the global cerebrospinal fluid (CSF) management market, is segmented into shunts and external drainage systems. In 2017, the shunts segment is expected to account for the largest share of the global cerebrospinal fluid (CSF) management market. The shunts market is further segmented into ventriculoperitoneal (VP), ventriculoatrial (VA), ventriculopleural (VPL), and lumboperitoneal (LP) shunts. Over the years, the disease burden of hydrocephalus has increased considerably, increasing the demand for CSF management devices as a method of treatment. Cerebrospinal fluid (CSF) management involves the use of devices such as shunts and external drainage systems to maintain the flow of CSF and drain excess fluid from the brain.

The cerebrospinal fluid (CSF) management market is projected to reach USD 1,561.1 million by 2022. Factors such as the high prevalence of hydrocephalus and the subsequent increase in the number of shunting procedures and the growing geriatric population are driving the growth of the CSF management market.

Browse and in-depth TOC onCerebrospinal Fluid Management Market
181 – Tables
44 – Figures
225 – Pages
View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/immunohistochemistry-market-121632939.html

Hydrocephalus can be treated with a shunt system; however, this treatment often includes complications. The most common shunt complications include malfunction, infection, and shunt obstruction. According to Pediatric Emergency Medicine Reports, about 40% of shunts fail within the first year and 56–80% by 10 years. Additionally, between 8–10% of shunts eventually become infected. Shunt malfunction can lead to an acute increase in intracranial pressure (ICP), causing irreparable impairment of the brain.

However, developing economies such as Brazil, Russia, India, China, and South Africa (BRICS) are among the fastest-growing economies in the world with a large patient base of hydrocephalus. The presence of such a huge patient base in this region, along with rising healthcare expenditure, is expected to serve as an opportunity for players in the CSF management market.

 Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=160672575

The dearth of trained professionals and complications related to CSF shunts may challenge market growth to a certain extent during the forecast period. For instance, in South Africa, there were 0.061 neurosurgeons per 100,000 people in 2016. This unavailability of medical professionals in developing countries is likely to reduce the chances of diagnosis and treatment of conditions requiring CSF management.

The major players in cerebrospinal fluid Management market include Medtronic (Ireland), Integra (US), B. Braun (Germany), DePuy Synthes (US), Spiegelberg GmbH & Co. KG (Germany), SOPHYSA (France), Natus Medical (US), Dispomedica GmbH (Germany), Delta Surgical Limited (UK), Argi Grup (Turkey), Moller Medical GmbH (Germany), G. SURGIWEAR LTD. (India), and Wellong Instruments Co., Ltd. (Taiwan).

Share this post:

Related Posts

Comments are closed.